Germany and France pursued distinct strategies for their COVID-19 vaccination drives against SARS-CoV-2, with Germany relying on large-scale "vaccinodromes"—major vaccination hubs—while France emphasized general practitioners and health professionals.
On January 4, 2021, France Info highlighted stark disparities in campaign progress. The U.S. had vaccinated over 4 million people, Israel 1 million, yet France had administered first doses to just over 500 individuals. Public frustration mounted over the sluggish pace. Health Minister Olivier Véran sought to reassure the public, pledging outcomes comparable to Germany's well-organized rollout featuring vaccinodromes.
France initially prioritized doctors and healthcare providers, explaining the measured start. In early January, the government accelerated by including healthcare workers over 50 in the first phase.
"Vaccinodromes" refer to expansive vaccination sites, often repurposed gyms or indoor arenas, as detailed by the German newspaper Süddeutsche Zeitung on December 25, 2020. Germany established 440 such centers nationwide, anticipating millions of doses in the weeks ahead. The campaign launched December 27, vaccinating 230,000 people by January 2.
These facilities feature wide aisles for efficient flow and isolated injection areas. Logistics for vaccine transport from storage to sites proved robust, despite a minor incident in Bavaria. Each center targets a capacity of 5,000 injections daily—though theoretical, as some paused operations during New Year's week due to low turnout.
France planned vaccination centers starting February 2021, beginning with those aged 75+. Subsequent phases would cover over-65s and beyond. Unlike Germany's broad initial focus on elderly, healthcare staff, and high-risk patients, France opted for phased audience targeting. Germany's model prioritized streamlined mass vaccination from day one.
Here's a France 24 report showcasing Germany's vaccinodromes:
